Inventor
EDWARDS WILSON
US15 patents
⚠️ This page may combine multiple inventors who share the name “EDWARDS WILSON”. Patents are grouped by organization below to help distinguish them — per-person disambiguation is on the roadmap.
JANSSEN PHARMACEUTICA NV
11 patentsUS10428134B2Oct 1, 2019
Immunoglobulins and uses thereof
JANSSEN PHARMACEUTICA NV7 citations92
US11767354B2Sep 26, 2023
Antibody-coupled cyclic peptide tyrosine tyrosine compounds as modulators of neuropeptide Y receptors
JANSSEN PHARMACEUTICA NV3 citations83
US11591379B2Feb 28, 2023
Antibody-coupled cyclic peptide tyrosine tyrosine compounds as modulators of neuropeptide Y receptors
JANSSEN PHARMACEUTICA NV3 citations83
US11401315B2Aug 2, 2022
Immunoglobulins and uses thereof
JANSSEN PHARMACEUTICA NV2 citations83
US10968265B2Apr 6, 2021
Antibody-coupled cyclic peptide tyrosine tyrosine compounds as modulators of neuropeptide Y receptors
JANSSEN PHARMACEUTICA NV4 citations83
US10858413B2Dec 8, 2020
Immunoglobulins and uses thereof
JANSSEN PHARMACEUTICA NV3 citations83
US10787495B2Sep 29, 2020
Immunoglobulins and uses thereof
JANSSEN PHARMACEUTICA NV3 citations83
US10640544B2May 5, 2020
Antibody-coupled cyclic peptide tyrosine tyrosine compounds as modulators of neuropeptide Y receptors
JANSSEN PHARMACEUTICA NV4 citations83
US12134636B2Nov 5, 2024
Immunoglobulins and uses thereof
JANSSEN PHARMACEUTICA NV0 citations72
US11236155B2Feb 1, 2022
Antibodies to pyroglutamate amyloid-β and uses thereof
JANSSEN PHARMACEUTICA NV4 citations70
US10875902B2Dec 29, 2020
Glucagon like peptide 1 (GLP-1) fusion peptide coupled cyclic peptide tyrosine tyrosine conjugates and uses thereof
JANSSEN PHARMACEUTICA NV0 citations49
JANSSEN BIOTECH INC
3 patentsUS10179808B2Jan 15, 2019
Kv1.3 antagonists and methods of use
JANSSEN BIOTECH INC0 citations51
US12030937B2Jul 9, 2024
Anti-idiotypic antibodies against anti-GPRC5D antibodies
JANSSEN BIOTECH INC0 citations45
US12162951B2Dec 10, 2024
Anti-idiotypic antibodies against anti-KLK2 antibodies
JANSSEN BIOTECH INC0 citations44